Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

Concerns exist that women are underrepresented in trials of cardiovascular medications. The authors sought to examine women’s participation and the reported safety and efficacy by gender for pivotal cardiovascular disease (CVD) trials submitted to the U.S. Food and Drug Administration (FDA) supporti...

Ausführliche Beschreibung